A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/48 (2006.01) C07K 16/30 (2006.01) C07K 16/40 (2006.01) C07K 16/46 (2006.01)
Patent
CA 2124218
A compound comprises a target cell-specific portion, such as an antibody specific to tumour cell antigens, and an inactivat- ing portion, such as an enzyme, capable of converting a substance which in its native state is able to inhibit the effect of a cytotox- ic agent into a substance which has less effect against said cytotoxic agent. The prolonged action of a cytotoxic agent at tumour sites is therefore possible whilst protecting normal tissues from the effects of the cytotoxic agent.
Enzacta R. & D. Limited
Smart & Biggar
LandOfFree
Cytotoxic drug therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytotoxic drug therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytotoxic drug therapy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1960426